Sciascia Thomas
- SEC CIK
- 0001229946
No open-market purchases or sales filed in the past year.
Current role at each company
- TRVI Trevi Therapeutics, Inc.Chief Scientific Officeras of Feb 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sciascia Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 (view filing) | Mar 25 | 1 day | Sciascia ThomasChief Scientific Officer | SSale | −2.63K | $6.60 | −$17.4K | −1.2%221.4K after | |
| Aug 21, 2024 (view filing) | Aug 19 | 2 days | Sciascia ThomasChief Scientific Officer | SSale | −16.5K | $2.96 | −$48.8K | −7.0%220.3K after | |
| Aug 16, 2024 (view filing) | Aug 14-16 | 2 days | Sciascia ThomasChief Scientific Officer | SSale | −31.5K | $2.77 | −$87.3K | −12.5%220.3K after | 3 lots |
| May 31, 2024 (view filing) | May 29 | 2 days | Sciascia ThomasChief Scientific Officer | SSale | −53.4K | $2.55 | −$136.1K | −19.9%214.4K after |